Researchers employed generative artificial intelligence to identify novel antimicrobial peptides effective against multidrug-resistant bacteria strains, representing a promising step in combating antibiotic resistance. Concurrently, Microsoft-led scientists revealed that AI protein design tools can generate modified toxins that evade current biosecurity screening software, exposing vulnerabilities in DNA synthesis safeguards and highlighting the need for ongoing biosecurity measures amidst advancing AI technologies.